Peroxisome proliferator-activated receptor-gamma activation inhibits interleukin-1beta -mediated platelet-derived growth factor-alpha receptor gene expression via CCAAT/enhancer-binding protein-delta in vascular smooth muscle cells.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Journal of Biological Chemistry

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 11278956
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• PPAR gamma-ligands inhibit migration mediated by multiple chemoattractants in vascular smooth muscle cells.

  1999cited by this paper
• Role of the CCAAT enhancer binding proteins (C/EBPs) in adipocyte differentiation.

  1999cited by this paper
• A high level of CCAAT-enhancer binding protein-delta expression is a major determinant for markedly elevated differential gene expression of the platelet-derived growth factor-alpha receptor in vascular smooth muscle cells of genetically hypertensive rats.

  1999cited by this paper
• Transcriptional regulation of the platelet-derived growth factor alpha receptor gene via CCAAT/enhancer-binding protein-delta in vascular smooth muscle cells.

  1999cited by this paper
• The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation.

  1998cited by this paper
• Posttranslational regulation of cyclooxygenase by tyrosine phosphorylation in cerebral endothelial cells.

  1998cited by this paper
• Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells.

  1998cited by this paper
• Transcriptional Regulation of Cyclooxygenase-2 in Mouse Skin Carcinoma Cells

  1998cited by this paper
• Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators.

  1998cited by this paper
• Induction of PDGF receptor-alpha in rat myofibroblasts during pulmonary fibrogenesis in vivo.

  1998cited by this paper
• Platelet-derived growth factor induces apoptosis in vascular smooth muscle cells: roles of the Bcl-2 family.

  1998cited by this paper
• Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats.

  1998cited by this paper
• Molecular structure and function of rat CCAAT-enhancer binding protein-delta gene promoter.

  1997cited by this paper
• Transcriptional activation of the mouse obese (ob) gene by CCAAT/enhancer binding protein alpha.

  1996cited by this paper
• The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation.

  1996cited by this paper
• Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia.

  1996cited by this paper
• Role of C/EBP proteins in hepatic and vascular smooth muscle transcription of human NHE1 gene.

  1995cited by this paper
• Molecular structure and transcriptional regulation of the gene for the platelet-derived growth factor alpha receptor in cultured vascular smooth muscle cells.

  1995cited by this paper
• C/EBP beta regulation of the tumor necrosis factor alpha gene.

  1994cited by this paper
• Transduction of mitogenic activity of platelet-derived growth factor (PDGF) AB by PDGF-beta receptor without participation of PDGF-alpha receptor in vascular smooth muscle cells.

  1993cited by this paper
• Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8.

  1993cited by this paper
• Mitogenic action of interleukin-1 alpha on vascular smooth muscle cells mediated by PDGF.

  1990cited by this paper
• Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA.

  1989cited by this paper
• Interleukin-1 promotes proliferation of vascular smooth muscle cells in coordination with PDGF or a monocyte derived growth factor.

  1989cited by this paper
• Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids.

  1988cited by this paper
• Regional Accumulations of T Cells, Macrophages, and Smooth Muscle Cells in the Human Atherosclerotic Plaque

  1986cited by this paper
• Modulation of alveolar macrophage-driven fibroblast proliferation by alternative macrophage mediators.

  1986cited by this paper
• Differential Effects of Human lnterleukin‐1 on Growth of Human Fibroblasts and Vascular Smooth Muscle Cells

  1985cited by this paper
• Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

  1983cited by this paper
• Studies on the pathogenesis of atherosclerosis. I. Adhesion and emigration of mononuclear cells in the aorta of hypercholesterolemic rats.

  1983cited by this paper
• Direct Evidence that the Greater Contractility of Resistance Vessels in Spontaneously Hypertensive Rats is Associated with a Narrowed Lumen, a Thickened Media, and an Increased Number of Smooth Muscle Cell Layers

  1978cited by this paper
• Intimal Injury and Regrowth in the Rabbit Aorta: MEDIAL SMOOTH MUSCLE CELLS AS A SOURCE OF NEOINTIMA

  1975cited by this paper

• Basic biology and roles of CEBPD in cardiovascular disease

  2025cites this paper
• A hierarchical and collaborative BRD4/CEBPD partnership governs vascular smooth muscle cell inflammation

  2021cites this paper
• Peroxisome proliferator-activated receptor-γ stimulates 11β-hydroxysteroid dehydrogenase type 1 in rat vascular smooth muscle cells

  2011cites this paper
• Therapeutic Implications of PPARγ in Cardiovascular Diseases

  2010cites this paper
• Peroxisome proliferator-activated receptor gamma and cardiovascular diseases.

  2009cites this paper
• PPARs and the Cardiovascular System

  2009cites this paper
• Effect of thiazolidinediones on equilibrative nucleoside transporter-1 in human aortic smooth muscle cells.

  2005cites this paper
• Growth stimulation of COX-2-negative pancreatic cancer by a selective COX-2 inhibitor.

  2005cites this paper
• Loss of CREB Regulation of Vascular Smooth Muscle Cell Quiescence in Diabetes

  2004cites this paper
• Thiazolidinediones: a new class of drugs for the therapy of ischemia-reperfusion injury.

  2004cites this paper
• Pleiotropic actions of PPAR gamma activators thiazolidinediones in cardiovascular diseases.

  2004cites this paper
• Peroxisome proliferator-activated receptors and the cardiovascular system.

  2003cites this paper
• The role of PPARgamma-dependent pathway in the development of cardiac hypertrophy.

  2003cites this paper
• Anti-inflammatory properties of lipid oxidation products

  2003cites this paper
• Novel actions of thiazolidinediones on vascular function and exercise capacity.

  2003cites this paper
• Mechanisms Regulating Adipocyte Expression of Resistin*

  2002cites this paper
• Content and activity of cAMP response element-binding protein regulate platelet-derived growth factor receptor-alpha content in vascular smooth muscles.

  2002cites this paper
• Roles of peroxisome proliferator-activated receptor gamma in cardiovascular disease.

  2002cites this paper
• Vascular Inflammation Is Negatively Autoregulated by Interaction Between CCAAT/Enhancer-Binding Protein-&dgr; and Peroxisome Proliferator-Activated Receptor-&ggr;

  2002cites this paper
• Peroxisome proliferator-activated receptor agonists, hyperlipidaemia, and atherosclerosis.

  2002cites this paper
• The role of PPARs in atherosclerosis.

  2002cites this paper
• Genetic analysis of four novel peroxisome proliferator activated receptor-gamma splice variants in monkey macrophages.

  2002cites this paper